#DCATWeek2025 is days away—is your schedule set yet? Don’t forget to attend the #MemberCompanyAnnouncementForum on Monday, March 17, at 9:40 a.m. ET, where Jennifer Cannon, president of commercial at Thermo Fisher Scientific, will deliver updates and insights about our #drugdevelopment initiatives. Additionally, join us at the “Partnering for Innovation in Manufacturing and Supply” event to learn how we helped NewAmsterdam Pharma Corporation navigate the complexities of a cardiovascular #clinicaltrial spanning 835 sites and 12,000+ patients. Our #casestudy, “Beyond supply: How a strategic partnership drove efficiency and innovation in global trials,” will be featured there. ?? When: Tuesday, March 18, from 8–9:30 a.m. ET ?? Where: InterContinental Barclay, Grand Ballroom (2nd Floor) ?? Who: Walk-ins available on a first-come, first-served basis Want to chat about these talks? Schedule a meeting here: https://spr.ly/60490pi1V
Fisher Clinical Services
制药业
Waltham,Massachusetts 16,399 位关注者
Fisher Clinical Services?, now part of our Patheon branded offerings.
关于我们
Thermo Fisher Scientific provides industry-leading pharma services solutions for drug development, clinical trial logistics and commercial manufacturing to customers through our Patheon brand. With more than 65 locations around the world, we provide integrated, end-to-end capabilities across all phases of development, including API, biologics, viral vectors, cGMP plasmids, formulation, clinical trials solutions, logistics services and commercial manufacturing and packaging. Built on a reputation for scientific and technical excellence, we provide pharma and biotech companies of all sizes instant access to a global network of facilities and experts across the Americas, Europe, Asia and Australia. We offer integrated drug development and clinical services tailored to fit your drug development journey through our Quick to CareTM program. Our Quick to ClinicTM programs for large and small molecules help you balance speed and risk during early development so you can file your IND quickly and successfully. Digital innovations such as our mysupply Platform and Pharma 4.0 enablement offer real-time data and a streamlined experience. Together with our customers, we’re rapidly turning pharmaceutical possibilities into realities.
- 网站
-
https://www.patheon.com/us/en/home.html
Fisher Clinical Services的外部链接
- 所属行业
- 制药业
- 规模
- 超过 10,001 人
- 总部
- Waltham,Massachusetts
- 类型
- 上市公司
- 领域
- Clinical Trials、Supply Chain、Logistics、Cold Chain和Comparator
地点
Fisher Clinical Services员工
动态
-
#Biotechnology breakthroughs are reshaping the #pharmaceutical industry as we know it, and Thermo Fisher Scientific is proud to support the #drugdevelopers driving these medical innovations. Whether you’re a rising startup or an established leader, our mission is to provide comprehensive #CDMO and #CRO capabilities that accelerate your journey from #molecule to #medicine to #market. And with a proven track record of helping over 120 customers across 350+ protocols—including #biotech companies of all shapes and sizes—we have the experience to fulfill these expectations. If you’re attending #DCATWeek2025 and want to learn more about our end-to-end offerings—including #earlydevelopment and #preclinicalcapabilities—schedule a meeting with us: https://spr.ly/6040LFhCG
-
-
#Drugdevelopment is rarely a straightforward journey, and it’s typical for challenges to arise at every step. At Thermo Fisher Scientific, we aim to simplify this often decades-long process by offering comprehensive capabilities through our Accelerator? Drug Development approach—allowing you to start here and stay here and eliminating the need for disconnected third-party vendors. Our comprehensive #CDMO and #CRO capabilities span the #drugdevelopment continuum, including services for: ?? Small molecule drugs ?? Large molecule drugs ?? Advanced therapies ?? Clinical supply ?? Clinical research ?? Commercialization To learn more about our end-to-end approach, schedule a meeting with us during #DCATWeek 2025: https://spr.ly/6042LXZzI
-
-
The #drugdevelopment journey is often decades-long. On average, it takes 10-15 years to research, develop, and manufacture one innovative treatment. And in cutting-edge fields like #genetherapy, this process can stretch up to 30 years. Thermo Fisher Scientific’s 360° #CDMO and #CRO solutions provide comprehensive capabilities for every stage of #drugdevelopment, helping to speed things up. That’s right—a recent study by the Tufts Center for the Study of Drug Development found that integrated #CDMO and #CRO solutions can help reduce #clinical timelines by an average of 7-19 months. We’re excited to showcase Accelerator? Drug Development at #DCATWeek2025. To arrange a private 1:1 meeting and learn about our end-to-end offerings for #biotech and #pharma companies, click here: https://spr.ly/6041INgPF
-
-
#ClinicalTrialSupplyEurope 2025 is around the corner, and Thermo Fisher Scientific looks forward to seeing you at this year’s event in #Spain. We’re especially excited to sponsor the #technologyandinnovation stream on Wednesday, February 26, at 10:30 a.m. CET., where Luke Wilson will present: ?? “#Biotech speed, #biopharma scale: Powered by #clinicaltrial innovation” Please join us for this 30-minute session as we discuss today’s most pressing #challenges and #opportunities in #clinicaltrial #supplymanagement. Want to schedule 1:1 time with our team? Simply book a meeting here: https://spr.ly/6041IIOoN
-
-
Before the #COVID-19 #pandemic, many people were unaware of the critical role #coldchain logistics played in safeguarding temperature-sensitive #biopharmaceuticals. The #pandemic changed that for good, as media coverage spotlighted its importance for transporting #mRNA-based #vaccines to people in need around the globe. Today, #coldchainlogistics remain crucial to preserving #drugintegrity from the #lab to the #patient—an important topic explored in Thermo Fisher Scientific’s new blog. Learn more here: https://spr.ly/6044IXL5E
-
#DCAT Week 2025 is around the corner. It’s a perfect opportunity for industry leaders to conduct high-level business meetings, foster strategic partnerships, and—most importantly—#connect. At Thermo Fisher Scientific, being connected means more than just networking—it's about partnering to advance #drugdevelopment and drive the #biopharmaceutical industry forward. Don’t miss the chance to #connect with our experts at #DCATWeek 2025 in #NYC and discover how our #CDMO and #CRO solutions can support your aspiration to get treatments to patients faster. Schedule a meeting with us here: https://spr.ly/6040IrWNK
-
-
At DCAT Week 2025, Thermo Fisher Scientific is excited to showcase our newly launched approach: Accelerator? Drug Development, 360° #CDMO and #CRO solutions. By seamlessly integrating our comprehensive #CDMO and #CRO capabilities, we can take you from #molecule to #medicine to #market faster than you ever thought possible. Say goodbye to fragmented, multi-vendor methods. From #earlydevelopment and #preclinical stages to #commercialization and post-approval, we can help enhance: ?? Speed ?? Simplicity ?? Scalability Schedule a meeting with our industry experts at #DCATWeek2025 in #NYC to discover more about our unique services and solutions: https://spr.ly/6045x7xQB
-
-
Please join Thermo Fisher Scientific at the 26th annual #ClinicalTrialSupplyEurope conference to discover our comprehensive #clinicaltrial capabilities. Visit us at booth #53, where our industry experts will showcase the benefits of partnering with an integrated #CDMO and #CRO to support your scientific studies from start to finish. Don’t miss our sponsored session on Wednesday, February 26, at 10:30 a.m. CET: “Biotech speed, biopharma scale: Powered by clinical trial innovation.” Featuring Luke Wilson, senior director of sales, this session will explore common challenges faced by today’s #drugdevelopers and innovative solutions to overcome them. Learn more: https://spr.ly/6040x0Cce
-
-
Going to #DCATWeek2025? Be sure to #connect with Thermo Fisher Scientific in #NewYorkCity to explore how we’re innovating #drugdevelopment. From game-changing treatments to industry-leading collaborations, there’s no limit to what we can accomplish together. We’re excited about where the industry is heading in 2025—and proud to partner with you to help improve patient lives worldwide. As a team, let’s shape the future of #biopharma. Schedule a meeting with us during #DCATWeek to learn more: https://spr.ly/6040xbQg0
-